Ebola research in NDM
12 February 2015
As of 11th March 2015, a Phase II clinical trial of a potential Ebola treatment is underway in Sierra Leone. The trial of the therapy, TKM-Ebola-Guinea, is being led by Professor Peter Horby. TKM-Ebola-Guinea is a synthetic small interfering RNA therapeutic designed specifically to target the strain of the Ebola virus responsible for the present outbreak in Guinea, Liberia and Sierra Leone. Professor Horby said: "There are still around 10 new cases of Ebola being diagnosed every day in Sierra Leone. It’s therefore essential that we push.